Munawwar Hussain

Assistant Professor

UAMS

Also affiliated: University of Arkansas Medical Center (2022)

6 h-index 12 pubs 95 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Munawwar Hussain's research focuses on multiple myeloma, investigating clinical outcomes and therapeutic advances for relapsed and refractory cases. His work includes studies on chimeric antigen receptor (CAR) T-cell therapy directed at B-cell maturation antigen (BCMA) in patients with multiple myeloma. Hussain also examines the role of bone-modifying agents and other treatments, such as belantamab mafodotin, in managing the disease and its complications like fractures. His research extends to the feasibility of outpatient stem cell transplantation for multiple myeloma patients and factors predictive of hospital admission. He has also explored the stem cell origin of cancer and its implications for drug and therapy development. Hussain's scholarship metrics include an h-index of 6, with 13 total publications and 95 total citations.

Metrics

h-index: 6
Publications: 12
Citations: 95

Positions

Assistant Professor publications 2022–2024

University of Arkansas for Medical Sciences Institution web page

Selected Publications

Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care (2024)

Cancers 2 citations DOI OpenAlex
Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article (2023)

Blood and Lymphatic Cancer Targets and Therapy 16 citations DOI OpenAlex
Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature (2023)

Cureus 2 citations DOI OpenAlex
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy (2022)

Bone Marrow Transplantation 22 citations DOI OpenAlex
Clinical Outcome of Patients with Relapsed Refractory Multiple Myeloma Listed for BCMA Directed Commercial CAR T Therapy (2022)

Blood 7 citations DOI OpenAlex
Parameters Influencing Count Recovery Post Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (2022)

Blood DOI OpenAlex
Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant (2022)

Blood DOI OpenAlex
MM-531 Case Control Study of Outcomes of Autologous Stem Cell Transplantation in Jehovah's Witness Multiple Myeloma Patients (2022)

Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex
Poster: MM-531 Case Control Study of Outcomes of Autologous Stem Cell Transplantation in Jehovah's Witness Multiple Myeloma Patients (2022)

Clinical Lymphoma Myeloma & Leukemia DOI OpenAlex
Corneal toxicity with belantamab mafodotin: Multi‐institutional real‐life experience (2022)

American Journal of Hematology 16 citations DOI OpenAlex
The use of bone-modifying agents in multiple myeloma (2022)

Blood Reviews 17 citations DOI OpenAlex
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission (2022)

Journal of Clinical Medicine 13 citations DOI OpenAlex
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma (2022)

American Journal of Hematology 6 citations DOI OpenAlex